Company Overview - Frequency Exchange Corp. has appointed Gail Edgell to its Advisory Board, bringing over 25 years of experience in the wellness industry [2][3] - The company is the parent of FREmedica Technologies Inc., which develops frequency-based digital wellness technologies [6] Gail Edgell's Experience - Edgell has held leadership roles in corporate wellness, professional supplements, biotechnology startups, and integrative clinical consulting [3] - She contributed to significant revenue growth at Designs for Health, scaling practitioner channel sales from $360,000 to $1.5 million in under three years [4] - At Bio-Botanical Research, she launched a practitioner partnership model that achieved $1 million in annualized revenue within 90 days [4] NIKKI Product Development - The flagship product, NIKKI, delivers programmable frequency wellness programs aimed at supporting cellular communication and overall wellbeing [6] - Originally developed for Lyme disease, NIKKI has expanded to address broader use cases, including sleep, pain, energy, immune support, and athletic recovery [7] - The technology is backed by ongoing testing and quality-of-life evaluations [7] Strategic Goals - Edgell's insights are expected to enhance the company's efforts to scale NIKKI's reach into professional, consumer, and community-based health channels [4]

Core Insights - Frequency Exchange Corp. has appointed Michael Moe to its Advisory Board, enhancing its governance and long-term value creation strategy [2][5]. Company Overview - Frequency Exchange Corp. (TSXV: FREQ; OTC: FRECF) is the parent company of FREmedica Technologies Inc., which specializes in frequency-based digital wellness technologies [7]. - The flagship product, NIKKI, offers programmable frequency wellness programs aimed at improving cellular communication and overall wellbeing [7]. Product Development - Initially designed to assist individuals with Lyme disease, the NIKKI platform has expanded its applications to include sleep, pain management, energy enhancement, immune support, and athletic recovery [8]. - The technology is backed by ongoing testing and evaluations focused on quality of life [8]. Leadership Background - Michael Moe, the new advisory board member, is the Founder and CEO of GSV, known for investing in transformative technology companies such as Facebook and Spotify [3]. - He has a strong background in growth research, having previously served as Head of Global Growth Research at Merrill Lynch and founded ThinkEquity Partners [4]. - Moe holds a BA in Political Science and Economics and is a CFA charterholder [6].

Core Insights - Frequency Exchange Corp. has appointed Scott Owen to its Board of Directors, enhancing its leadership team [2][4] - Scott Owen brings over 30 years of experience in global business development and has held senior leadership roles with P&L responsibilities exceeding $250 million [3] - Owen's track record includes closing multiple multi-year enterprise deals valued over $100 million, with a notable partnership contributing $950 million in attributed revenue over five years [3] Company Overview - Frequency Exchange Corp. is the parent company of FREmedica Technologies Inc., which specializes in frequency-based digital wellness technologies [5] - The flagship product, NIKKI, offers programmable frequency wellness programs aimed at supporting cellular communication and overall wellbeing [5] - Initially developed for Lyme disease, the NIKKI platform has expanded to address various use cases, including sleep, pain, energy, immune support, and athletic recovery [6]